Digital pathology
Paige
Digital pathology AI applications for cancer pathology, including Paige Prostate.
Last updated: June 8, 2026
Back to directoryIndica Labs HALO AP and HALO AP Dx medical AI product profile
Digital pathology platform family that combines case-centric whole-slide-image review, AI-enabled pathology workflows, integrations, and scanner-specific FDA-cleared HALO AP Dx primary-diagnosis use.
Digital pathology
Best fit
Pathology groups that need an enterprise digital pathology platform with AI-ready workflows, LIS/LIMS integration, remote review, and careful separation of cleared diagnostic viewing from research-use AI modules.
- Primary use case
- AI-ready digital pathology case management, primary-diagnosis viewing where cleared, remote review, LIS/LIMS integration, clinical AI module deployment, and whole-slide-image quality or biomarker analysis workflows
- Audience
- Anatomic pathology labs, digital pathology programs, cancer centers, health-system pathology departments, clinical research teams, and governance committees evaluating AI-ready whole-slide-image workflows
- Risk level
- High
- Pricing signal
- Enterprise pathology platform and services pricing is not public; verify current HALO AP, HALO AP Dx, clinical AI module, cloud deployment, scanner, integration, and support terms.
- Official sources
- 5 official sources
Compare within workflow: Digital pathology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Indica Labs HALO AP and HALO AP Dx as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Separate HALO AP, HALO AP Dx, HALO AI, and each clinical AI algorithm before procurement. Confirm scanner, display, version, module, country, and intended use against FDA 510(k), CE-IVDR, UKCA, or local requirements before diagnostic deployment. |
|---|---|
| Privacy | Review cloud versus on-premise deployment, LIS/LIMS and WSI data flows, patient and case metadata, role permissions, audit logs, support access, AWS-hosted services, deidentified exports, retention, BAA or DPA terms, and whether product-service data can be reused. |
| Evidence | Require module-specific validation, scanner and stain compatibility, local case-mix testing, pathologist agreement, quality-control metrics, false-positive and false-negative review, and evidence that the selected AI output supports the intended pathology decision. |
| Workflow | Best governed as an enterprise digital pathology platform where pathologists retain diagnostic responsibility, AI modules are released only after local validation, and reports, consults, tumor boards, molecular workflows, and downtime procedures are explicitly mapped. |
Where Indica Labs HALO AP and HALO AP Dx fits
Indica Labs describes HALO AP as an AI-powered, pathologist-driven digital pathology platform for primary diagnosis, remote working, LIS/LIMS integration, and clinical AI tools; public product materials distinguish HALO AP Dx's FDA-cleared primary-diagnosis scope from HALO AP and several AI modules that are research-use-only in the United States, while FDA K232833 documents HALO AP Dx clearance for a specific whole-slide-image configuration.
Not for: Autonomous diagnosis, assuming every HALO AP or HALO Clinical AI module is FDA-cleared, using research-use algorithms for diagnostic decisions, or deploying without scanner/version-specific regulatory and validation review.
What to verify before using Indica Labs HALO AP and HALO AP Dx
- Which product and module are in scope: HALO AP, HALO AP Dx, HALO Clinical AI, Prostate AI, Breast IHC AI, Lung PD-L1 AI, SlideQC BF, macrodissection tools, HALO AI, or third-party algorithms.
- Whether the exact scanner, display, software version, geography, and intended use match FDA, CE-IVDR, UK, or local authorization; HALO AP Dx clearances are scanner- and configuration-specific.
- How whole-slide images, LIS/LIMS data, patient identifiers, case metadata, cloud hosting, support access, deidentified exports, audit trails, Part 11 controls, retention, and customer ownership are handled.
- Local validation for slide quality, scanner mix, stain variability, case assembly, AI module performance, pathologist review, false positives or negatives, downtime, report routing, and second-opinion workflows.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- indicalab.com / clinical-products / halo-ap
- indicalab.com / clinical-products
- www.accessdata.fda.gov / scripts / cdrh
- www.hamamatsu.com / us / en
- indicalab.com / privacy-policy
Related medical AI products
Digital pathology
PathAI
AI-enabled digital pathology platform with image management and algorithm access.
Digital pathology
Hologic Genius Digital Diagnostics
FDA-cleared digital cytology system combining volumetric imaging, Genius Cervical AI, image management, and cytologist or pathologist review.
Digital pathology
Ibex Medical Analytics
Clinical-grade AI pathology platform for cancer diagnostics and pathology workflow support.